Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Rifat Hasina   and   Nicole Cipriani.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.093
         
        
        
     
 
    
        
        - 
            Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
            
            
                Score: 0.057
            
         
        
        - 
            Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population. Head Neck. 2018 04; 40(4):784-792.
            
            
                Score: 0.036